ARKGvsLFSCETF Comparison
VS
ARK Genomic Revolution ETF (ARKG) belongs to the BioTech & Genomics segment. F/m Emerald Life Sciences Innovation ETF (LFSC) is part of the Life Sciences segment. Both ETFs have the same top 3 sector exposures: and Healthcare. ARKG is less expensive with a Total Expense Ratio (TER) of 0.75%, versus 0.79% for LFSC. ARKG is up 29.47% year-to-date (YTD) with +$39M in YTD flows. LFSC performs worse with 23.23% YTD performance, and +$8M in YTD flows. Run a side-by-side ETF comparison of ARKG and LFSC below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
ARKG vs LFSC performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 07/24/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | ARKG LFSC | -1.87%+4.17% | +27.92%+20.39% | +29.47%+23.23% | +45.31%+82.30% | +4.16%n/a | -54.66%n/a |
| Flows | ARKG LFSC | +$81M+$2M | +$62M+$3M | +$39M+$8M | -$3M+$17M | -$550M- | -$2.57B- |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | ARKG LFSC | +44.86%+26.23% | +42.64%+26.91% | +43.40%n/a | +45.98%n/a |
| Max drawdown | ARKG LFSC | -13.14%-6.53% | -27.52%-16.25% | -51.67%n/a | -79.29%n/a |
| Max drawdown duration | ARKG LFSC | 18d20d | 126d168d | 1058dn/a | 1814dn/a |
Trading data
ARKG | LFSC | |
Last sale 7/27/2026 at 1:30 PM | $37.75 | $45.30 |
| Previous close 07/24/2026 | $37.81 | $45.10 |
| Consolidated volume 07/24/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Advertisement
Main metrics
Last update 7/27/2026 at 1:30 PM
Live
Closed
ARKG | LFSC | |
|---|---|---|
| Last price | $37.75 | $45.30 |
| 1D performance | -0.16% | +0.44% |
| AuM | $1.53 B | $123.48 M |
| E/R | 0.75% | 0.79% |
Characteristics
ARKG | LFSC | |
|---|---|---|
| Management strategy | Active | Active |
| Provider | Ark Investment | Emerald Group |
| Benchmark | - | - |
| N° of holdings | 31 | 40 |
| Asset class | - | - |
| Trailing 12m distribution yield | Join | Join |
| Inception date | April 2, 2019 | October 31, 2024 |
| ESG | No | No |
Advertisement
Exposure
Countries
ARKG
USA
86.99%
Other
13.01%
LFSC
USA
90.9%
United Kingdom
7.04%
Other
2.06%
Sectors
ARKG
Healthcare
96.93%
Other
3.07%
LFSC
Healthcare
98.03%
Other
1.97%
Advertisement
Diversification
ARKG
Total weight of top 15 holdings out of 15
74.95%
LFSC
Total weight of top 15 holdings out of 15
73.24%
Top 15 holdings
Data as of June 30, 2026
ARKG
Twist Bioscience Corp.
9.15%
Tempus AI, Inc.
7.64%
Absci Corp.
7.01%
10X Genomics, Inc.
7.00%
CRISPR Therapeutics AG
6.56%
Personalis, Inc.
6.19%
Beam Therapeutics, Inc.
4.34%
Guardant Health, Inc.
4.28%
Natera, Inc.
4.11%
Illumina, Inc.
3.98%
Veracyte, Inc.
3.24%
CareDx, Inc.
3.08%
Recursion Pharmaceuticals, Inc.
2.85%
Eli Lilly & Co.
2.81%
Compass Pathways Plc
2.70%
LFSC
Travere Therapeutics, Inc.
8.37%
Cogent Biosciences, Inc.
7.18%
LivaNova Plc
7.04%
Spyre Therapeutics, Inc.
6.71%
Guardant Health, Inc.
5.56%
Corcept Therapeutics, Inc.
5.27%
Mirum Pharmaceuticals, Inc.
5.25%
BillionToOne, Inc.
4.25%
Cytokinetics, Inc.
4.13%
Veradermics, Inc.
3.76%
United Therapeutics Corp.
3.55%
Trevi Therapeutics, Inc.
3.50%
Savara, Inc.
3.20%
Dianthus Therapeutics, Inc.
2.77%
Nektar Therapeutics
2.70%
Frequently asked questions about ARKG and LFSC
How have the ARKG and LFSC ETFs performed in 2026?
As of July 24, 2026, ARKG is up 29.47% year-to-date (YTD), while LFSC has returned 23.23%. That puts ARKG better performer ahead so far this year.
Which ETF is attracting more investor money: ARKG or LFSC?
Year-to-date, the ARKG ETF saw +$39M in flows, compared to +$8M for LFSC.
Which ETF is more volatile: ARKG or LFSC?
Over the past year, ARKG had a volatility of 42.64%, while LFSC experienced 26.91%.
Which ETF is bigger: ARKG or LFSC?
As of July 24, 2026, ARKG holds $1.53 B in assets under management (AUM), while LFSC manages $123.48 M.
What sectors do the ARKG and LFSC ETFs invest in?
ARKG leans toward sectors like Healthcare. Meanwhile, LFSC focuses on Healthcare.
What are the top holdings of the ARKG ETF and LFSC ETF?
ARKG top holdings include Twist Bioscience Corp., Tempus AI, Inc. and Absci Corp.. LFSC holds in its top three: Travere Therapeutics, Inc., Cogent Biosciences, Inc. and LivaNova Plc.
Which ETF is more diversified: ARKG or LFSC?
ARKG holds 31 securities with 74.95% of its assets in the top 15. LFSC has 40 securities and a top 15 weight of 73.24%.
Advertisement
Latest news about ARKG & LFSC
Advertisement
